Clinical Trial Update: Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Triprilimab (JS001) in combination with chemotherapy and local treatment for metastatic nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Triprilimab (JS001)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN